THORN RUN PARTNERS

Lobbying for AMYLYX · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.

Budget/Appropriations

Labor-H Appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.